United Therapeutics Corp. (UTHR)
554.21
-4.89
(-0.87%)
USD |
NASDAQ |
Nov 20, 16:00
551.00
-3.21
(-0.58%)
After-Hours: 19:45
United Therapeutics Gross Profit (TTM) : 2.752B for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.752B |
| June 30, 2026 | 2.717B |
| March 31, 2026 | 2.744B |
| December 31, 2025 | 2.798B |
| September 30, 2025 | 2.772B |
| June 30, 2025 | 2.739B |
| March 31, 2025 | 2.665B |
| December 31, 2024 | 2.568B |
| September 30, 2024 | 2.451B |
| June 30, 2024 | 2.325B |
| March 31, 2024 | 2.220B |
| December 31, 2023 | 2.07B |
| September 30, 2023 | 1.959B |
| June 30, 2023 | 1.898B |
| March 31, 2023 | 1.803B |
| December 31, 2022 | 1.785B |
| September 30, 2022 | 1.733B |
| June 30, 2022 | 1.671B |
| March 31, 2022 | 1.643B |
| December 31, 2021 | 1.563B |
| September 30, 2021 | 1.532B |
| June 30, 2021 | 1.472B |
| March 31, 2021 | 1.398B |
| December 31, 2020 | 1.375B |
| September 30, 2020 | 1.307B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.320B |
| March 31, 2020 | 1.331B |
| December 31, 2019 | 1.331B |
| September 30, 2019 | 1.398B |
| June 30, 2019 | 1.391B |
| March 31, 2019 | 1.427B |
| December 31, 2018 | 1.429B |
| September 30, 2018 | 1.491B |
| June 30, 2018 | 1.556B |
| March 31, 2018 | 1.599B |
| December 31, 2017 | 1.620B |
| September 30, 2017 | 1.588B |
| June 30, 2017 | 1.547B |
| March 31, 2017 | 1.514B |
| December 31, 2016 | 1.526B |
| September 30, 2016 | 1.525B |
| June 30, 2016 | 1.516B |
| March 31, 2016 | 1.454B |
| December 31, 2015 | 1.393B |
| September 30, 2015 | 1.344B |
| June 30, 2015 | 1.258B |
| March 31, 2015 | 1.211B |
| December 31, 2014 | 1.163B |
| September 30, 2014 | 1.082B |
| June 30, 2014 | 1.065B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Liquidia Corp. | 575.57M |
| Alnylam Pharmaceuticals, Inc. | 3.874B |
| Exelixis, Inc. | 2.404B |
| Gilead Sciences, Inc. | 24.85B |
| Insmed, Inc. | 1.272B |